Incannex Healthcare Inc.
IXHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873875
No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Incannex Healthcare Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 12 | 7 | −5 |
| Shares | 442.0K | 336.7K | −105.3K (−23.8%) |
| Value | $879.5K | $713.8K | −$165.7K (−18.8%) |
New holders (1)
Institutions that held Incannex Healthcare Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 47,274 | $100.2K | 0.00% |
Sold out (6)
Institutions that held Incannex Healthcare Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Toroso Investments, LLC | 130,026 | $258.8K |
| Virtu Financial LLC | 36,622 | $73.0K |
| Citadel Advisors LLC | 24,152 | $48.1K |
| HRT Financial LP | 23,752 | $47.0K |
| Catalyst Funds Management Pty Ltd | 50 | $100 |
| JPMorgan Chase & Co | 2 | $4 |